A developer-targeting campaign leveraged malicious Next.js repositories to trigger a covert RCE-to-C2 chain through standard ...
A homegrown biopharma developing cell therapies for cancers and other diseases is set to be acquired by Gilead Sciences — for ...
D.C.'s largest community health center is taking over two medical practices in the District. Here's what it's getting in return.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results